Inventor · disambiguated record
Stanislas Mayer
Also filed as: MAYER STANISLAS
8 granted patents·10 pending applications·44 citations·filing 2005–2024
80Inventor score
Files withDOMAIN THERAPEUTICS9MERCK PATENT GMBH3SCHANN STEPHAN2CV THERAPEUTICS INC1ERMIUM THERAPEUTICS1
Top patents by PatentIndex Score
18 records- 0188US9029393B2Adenosine receptor ligands and uses thereofSCHANN STEPHAN·Filed 2010·Granted May 12, 2015·35 cites·22 claims
- 0282US11008323B2Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2016·Granted May 18, 2021·5 cites·13 claims
- 0369US7300923B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2005·Granted Nov 27, 2007·2 cites·25 claims
- 0467US2025049814A15-azaindazole derivatives as adenosine receptor antagonistsMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 0563US9434734B2Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2013·Granted Sep 6, 2016·1 cites·15 claims
- 0662US8962627B2Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptorsSCHANN STEPHAN·Filed 2010·Granted Feb 24, 2015·1 cites·17 claims
- 0753US12194051B25-azaindazole derivatives as adenosine receptor antagonistsMERCK PATENT GMBH·Filed 2019·Granted Jan 14, 2025·0 cites·15 claims
- 0850US2025320224A1Novel par-2 inhibitorsDOMAIN THERAPEUTICS·Filed 2023·Application pending·0 cites
- 0946US2019152979A1Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1044US2022089609A1Substituted quinazolinone derivatives and their use as positive allosteric modulators of mglur4DOMAIN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 1144US2024066027A1Novel par-2 inhibitorsDOMAIN THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1243US2024018125A1Cyclic isothiourea derivatives as cxcr4 modulatorsERMIUM THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1340US2009093476A1Pyrrolo[1,2-a]quinoxaline derivatives as adenosine a3 receptor modulators and uses thereofFAUST PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 1439US2021380606A15-azaindazole derivatives as adenosine receptor antagonistsMERCK PATENT GMBH·Filed 2019·Application pending·0 cites
- 1538US10221179B2Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2015·Granted Mar 5, 2019·0 cites·21 claims
- 1638US2022298135A15-heteroaryl-pyridin-2-amine compounds as neuropeptide ff receptor antagonistsDOMAIN THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1737US2022144853A1Imidazoline derivatives as cxcr4 modulatorsUNIV PARIS·Filed 2020·Application pending·0 cites
- 1831US11472806B2Substituted heterocyclic compounds as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2018·Granted Oct 18, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Stanislas Mayer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →